Citadel Advisors
CPIX icon

Citadel Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Citadel Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.1K Sell
16,643
-5,314
-24% -$20.5K ﹤0.01% 12375
2025
Q4 		$87.4K Sell
21,957
-19,488
-47% -$57.8K ﹤0.01% 11739
2025
Q3 		$129K Sell
41,445
-32,961
-44% -$110K ﹤0.01% 11646
2025
Q2 		$249K Buy
74,406
+48,592
+188% +$230K ﹤0.01% 10216
2025
Q1 		$109K Buy
+25,814
New +$107K ﹤0.01% 11337
2024
Q3 		– Sell
-834
Closed -$1.15K – 14336
2024
Q2 		$1.28K Sell
834
-2,788
-77% -$4.38K ﹤0.01% 13842
2024
Q1 		$6.08K Buy
3,622
+87
+2% +$174 ﹤0.01% 13700
2023
Q4 		$6.15K Sell
3,535
-2,398
-40% -$4.39K ﹤0.01% 13372
2023
Q3 		$11.2K Sell
5,933
-13,776
-70% -$23.1K ﹤0.01% 13019
2023
Q2 		$29K Sell
19,709
-1,624
-8% -$2.8K ﹤0.01% 12391
2023
Q1 		$41.6K Sell
21,333
-7,789
-27% -$18.5K ﹤0.01% 12391
2022
Q4 		$65.5K Buy
+29,122
New +$67.6K ﹤0.01% 11792
2021
Q4 		– Sell
-12,021
Closed -$32K – 13883
2021
Q3 		$32K Buy
+12,021
New +$35.7K ﹤0.01% 13550
2021
Q2 		– Sell
-17,005
Closed -$52K – 13738
2021
Q1 		$52K Buy
+17,005
New +$55.3K ﹤0.01% 12883
2016
Q3 		– Sell
-12,895
Closed -$58K – 7285
2016
Q2 		$58K Buy
12,895
+1,671
+15% +$7.66K ﹤0.01% 6374
2016
Q1 		$50K Buy
+11,224
New +$53.5K ﹤0.01% 6248
2014
Q2 		– Sell
-14,475
Closed -$65K – 7988
2014
Q1 		$65K Buy
+14,475
New +$68.9K ﹤0.01% 6549
2013
Q3 		– Sell
-38,959
Closed -$199K – 6744
2013
Q2 		$199K Buy
+38,959
New +$194K ﹤0.01% 4677

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors's CPIX Position: Q1 2026 in Review

Citadel Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 24% in Q1 2026, selling an estimated $20.5K and leaving 16,643 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12375.

Citadel Advisors first reported a position in CPIX in Q2 2013 and has held it in 18 quarters since. The position peaked at $249K in Q2 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Citadel Advisors held 16,643 shares of Cumberland Pharmaceuticals worth $54.1K as of Q1 2026.
  • Citadel Advisors sold 5,314 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $20.5K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12375 holding.
  • Citadel Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 18 quarters since.
  • Citadel Advisors's Cumberland Pharmaceuticals position peaked at $249K in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.